NIH-funded research NIH-funded research

Circadian rhythms and how they guide making proteins

Official title: Mechanisms of Circadian Clock Control of mRNA Translation

Funded at Texas A&m University · NIH-11309269 · Data updated 2026-11-12

This NIH grant looks at how the body’s clock controls protein production, which could affect how drugs work and how cells stay healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas A&m University
NIH-funded
Lab location1 site (College Station, United States)
Project startMay 1, 2018
Project endMarch 31, 2028
Funding year2026
Award (this year)$156,590
NIH project number3R35GM126966-09S1
Project IDNIH-11309269 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancers or cardiac diseases where circadian rhythms affect disease progression or drug response may benefit from advances in this area.

Less likely to help

People without conditions linked to circadian disruption or protein translation pathways may not directly benefit.

What this research studies

Researchers at Texas A&M are studying how the circadian clock influences protein production and quality in cells, using yeast-like models to understand the mechanism. They focus on how the clock affects translation steps, including how ribosomes read through stop signals and how tRNA synthetases contribute to accurate protein building. The work could reveal new ways the clock changes protein diversity over the day, which might impact disease processes and treatment timing. The project builds on prior findings about translation control and ribosome composition to test how these clock-driven changes occur in living systems.

Why it matters

Potential benefit: If successful, this work could inform timing strategies for therapies and improve understanding of diseases influenced by circadian biology.

How similar studies have gone: Previous work showed clock control of translation initiation and ribosome behavior, with potential for translation into therapies.

Where this research is happening

  • Texas A&m University
    College Station, United States
    Active

Researchers

  • Principal investigator: Bell-Pedersen, Deborah — Texas A&m University
  • Study coordinator: Bell-Pedersen, Deborah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.